Galegenimab (RG 6147) is an antigen-binding fragment (Fab) targeting HtrA1, capable of blocking proteolytic cleavage of biglycan (an HtrA1 substrate), suitable for age-related macular degeneration (AMD) research.
Purity:
95.00%
CAS Number:
[2403683-24-7]
Target:
Serine Protease
* VAT and and shipping costs not included. Errors and price changes excepted